Royalty Pharma
RPRX
$28.07
Share price
-1.09%
Change (1 day)
-18.23%
Change (1 year)
Categories
Royalty Pharma (RPRX) - Total assets
Total assets on the balance sheet as of December 2023 : $16.38 B
According to Royalty Pharma's latest financial reports the company's total assets are $16.38 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Royalty Pharma - Total assets on balance sheet (from 2019 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $16.38 B | -2.57% |
| 2022-12-31 | $16.81 B | -4.01% |
| 2021-12-31 | $17.51 B | 9.34% |
| 2020-12-31 | $16.02 B | 28.68% |
| 2019-12-31 | $12.44 B | 9.5% |
| 2018-12-31 | $11.37 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $73.21 B | 346.92% | 🇺🇸 USA |
 Eli Lilly LLY | $63.94 B | 290.33% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.90 B | -94.48% | 🇺🇸 USA |